IBOV 177,098 ▼ 1.80% COLCAP 2,118 ▼ 0.22% MERVAL 2,738,355 ▼ 1.96% IPC MEX 70,187 ▲ 0.22% BVL PERÚ 19,767 ▲ 0.37% STOXX 50 5,861 ▲ 0.91% DAX 24,137 ▲ 0.76% CAC 8,008 ▲ 0.35% FTSE 10,325 ▲ 0.58% IBEX 17,655 ▲ 0.46% FTSE MIB 49,481 ▲ 1.00% AEX 1,010 ▲ 1.07% OMXS30 3,048 ▲ 0.05% WIG 132,379 ▲ 1.71% PSI 9,072 ▲ 0.24% SMI 13,213 ▲ 0.71% BEL 20 5,509 ▲ 0.71% S&P 500 7,444 ▲ 0.58% DOW 49,693 ▼ 0.14% NASDAQ 26,402 ▲ 1.20% RUSSELL 2,844 ▲ 0.04% TSX 34,041 ▼ 0.73% NIKKEI 63,272 ▲ 1.37% HANG SENG 26,388 ▼ 0.07% SHANGHAI 4,243 ▲ 0.42% SHENZHEN 16,090 ▲ 1.20% KOSPI 7,844 ▲ 0.28% KOSDAQ 1,177 ▼ 2.52% TWSE 41,375 ▼ 0.99% SENSEX 74,609 ▼ 1.85% NIFTY 23,413 ▼ 1.69% PSEi 5,947 ▼ 0.67% JCI 6,723 ▼ 2.64% KLCI 1,746 ▲ 0.06% STI 5,004 ▲ 1.24% SET 1,517 ▲ 1.88% ASX 200 8,630 ▼ 0.82% NZX 50 13,063 ▼ 0.13% JSE TOP 40 109,782 ▲ 0.66% EGX 30 53,416 ▼ 1.19% TASI 11,020 ▼ 0.17% USD/BRL 5.00 ▲ 1.93% USD/COP 3,780 ▼ 0.16% USD/ARS 1,392 ▲ 0.47% USD/MXN 17.17 ▼ 0.33% USD/PEN 3.42 ▲ 1.69% EUR/BRL 5.86 ▲ 1.74% EUR/USD 1.17 ▼ 0.17% GBP/USD 1.35 ▼ 0.10% USD/JPY 157.87 ▲ 0.13% USD/CNY 6.79 ▼ 0.03% USD/INR 95.62 ▼ 0.01% USD/KRW 1,490 ▼ 0.19% USD/ZAR 16.40 ▼ 0.65% USD/NGN 1,368 ▼ 0.18% USD/EGP 52.87 — 0.00% USD/TRY 45.41 ▲ 0.01% USD/RUB 73.59 ▼ 0.32% USD/CHF 0.78 ▲ 0.17% USD/CAD 1.37 ▲ 0.04% USD/HKD 7.83 ▲ 0.02% USD/SGD 1.27 ▲ 0.06% BRENT 105.59 ▼ 2.02% WTI 100.97 ▼ 1.18% GOLD 4,699 ▲ 0.46% SILVER 88.22 ▲ 3.63% COPPER 6.63 ▲ 2.19% NATGAS 2.85 ▲ 0.35% IRON ORE 161.91 ▲ 45.32% BTC 79,674 ▼ 1.00% ETH 2,262 ▼ 0.56% SELIC 14.50% IBOV 177,098 ▼ 1.80% COLCAP 2,118 ▼ 0.22% MERVAL 2,738,355 ▼ 1.96% IPC MEX 70,187 ▲ 0.22% BVL PERÚ 19,767 ▲ 0.37% STOXX 50 5,861 ▲ 0.91% DAX 24,137 ▲ 0.76% CAC 8,008 ▲ 0.35% FTSE 10,325 ▲ 0.58% IBEX 17,655 ▲ 0.46% FTSE MIB 49,481 ▲ 1.00% AEX 1,010 ▲ 1.07% OMXS30 3,048 ▲ 0.05% WIG 132,379 ▲ 1.71% PSI 9,072 ▲ 0.24% SMI 13,213 ▲ 0.71% BEL 20 5,509 ▲ 0.71% S&P 500 7,444 ▲ 0.58% DOW 49,693 ▼ 0.14% NASDAQ 26,402 ▲ 1.20% RUSSELL 2,844 ▲ 0.04% TSX 34,041 ▼ 0.73% NIKKEI 63,272 ▲ 1.37% HANG SENG 26,388 ▼ 0.07% SHANGHAI 4,243 ▲ 0.42% SHENZHEN 16,090 ▲ 1.20% KOSPI 7,844 ▲ 0.28% KOSDAQ 1,177 ▼ 2.52% TWSE 41,375 ▼ 0.99% SENSEX 74,609 ▼ 1.85% NIFTY 23,413 ▼ 1.69% PSEi 5,947 ▼ 0.67% JCI 6,723 ▼ 2.64% KLCI 1,746 ▲ 0.06% STI 5,004 ▲ 1.24% SET 1,517 ▲ 1.88% ASX 200 8,630 ▼ 0.82% NZX 50 13,063 ▼ 0.13% JSE TOP 40 109,782 ▲ 0.66% EGX 30 53,416 ▼ 1.19% TASI 11,020 ▼ 0.17% USD/BRL 5.00 ▲ 1.93% USD/COP 3,780 ▼ 0.16% USD/ARS 1,392 ▲ 0.47% USD/MXN 17.17 ▼ 0.33% USD/PEN 3.42 ▲ 1.69% EUR/BRL 5.86 ▲ 1.74% EUR/USD 1.17 ▼ 0.17% GBP/USD 1.35 ▼ 0.10% USD/JPY 157.87 ▲ 0.13% USD/CNY 6.79 ▼ 0.03% USD/INR 95.62 ▼ 0.01% USD/KRW 1,490 ▼ 0.19% USD/ZAR 16.40 ▼ 0.65% USD/NGN 1,368 ▼ 0.18% USD/EGP 52.87 — 0.00% USD/TRY 45.41 ▲ 0.01% USD/RUB 73.59 ▼ 0.32% USD/CHF 0.78 ▲ 0.17% USD/CAD 1.37 ▲ 0.04% USD/HKD 7.83 ▲ 0.02% USD/SGD 1.27 ▲ 0.06% BRENT 105.59 ▼ 2.02% WTI 100.97 ▼ 1.18% GOLD 4,699 ▲ 0.46% SILVER 88.22 ▲ 3.63% COPPER 6.63 ▲ 2.19% NATGAS 2.85 ▲ 0.35% IRON ORE 161.91 ▲ 45.32% BTC 79,674 ▼ 1.00% ETH 2,262 ▼ 0.56% SELIC 14.50%
since 2009
Wednesday, May 13, 2026

Study: Sleep and Anxiety Prescription Drugs Kill More Than Cocaine

By · October 29, 2019 · 2 min read

RIO DE JANEIRO, BRAZIL – The World Health Organization (WHO) and scientists at the University of British Columbia, Canada, caution that drugs containing the compound benzodiazepine cause addiction and withdrawal symptoms.

According to researchers, there is one component in particular that represents a health hazard: benzodiazepine (BZD).
According to researchers, there is one component in particular that represents a health hazard: benzodiazepine (BZD). (Photo: internet reproduction)

The frequent and indiscriminate use of sleep and anxiety pills poses a greater risk of death than the use of drugs such as cocaine and heroin. The findings are from two studies published in the scientific journal American Journal of Public Health.

According to researchers, there is one component in particular that represents a health hazard: benzodiazepine (BZD). The first study, by the University of British Columbia (UBC) in Vancouver, Canada, showed that excessive intake of benzodiazepine poses a risk of death 1.86 times higher than the use of illegal drugs.

The survey was conducted with 2802 subjects taking benzodiazepines, who were interviewed twice a year for five and a half years. By the end of the study, 18.8 percent of the individuals in the group had died. The researchers observed that even after isolating other factors, such as illegal drug use and high-risk behaviors, the mortality rate remained high among those who used the compound.

A second study of a smaller part of the same group examined the link between benzodiazepine use and hepatitis C infection, and found that the infection rate was 1.67 times higher among those who used compound-based drugs.

“The interesting thing about these findings is that it is a prescribed drug and people think it is safe. But we’re probably prescribing these drugs excessively and it’s causing damage,” scientist Keith Ahamad told Vancouver Sun.

A report from the World Health Organization (WHO) alerts that benzodiazepine should only be prescribed to treat “severe, incapacitating anxiety or insomnia that cause extreme distress”. It recommends that doctors take into account that the compound causes addiction and withdrawal syndrome – so it should be used in a minimum effective dose and for as little time as possible.

Read More from The Rio Times

Latin American financial intelligence, daily

Breaking news, market reports, and intelligence briefs — for investors, analysts, and expats.

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.